# Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand

> **NCT00409591** · PHASE3 · TERMINATED · sponsor: **Institut de Recherche pour le Developpement** · enrollment: 435 (actual)

## Conditions studied

- HIV Infections
- Pregnancy

## Interventions

- **DRUG:** Maternal and infant nevirapine
- **DRUG:** Maternal placebo and infant nevirapine
- **DRUG:** Maternal lopinavir+ritonavir
- **DRUG:** zidovudine

## Key facts

- **NCT ID:** NCT00409591
- **Lead sponsor:** Institut de Recherche pour le Developpement
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2010-11
- **Final completion:** 2015-06
- **Target enrollment:** 435 (ACTUAL)
- **Why stopped:** Change in National PMTCT guidelines in Thailand
- **Last updated:** 2016-01-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00409591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00409591, "Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00409591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*